Showing 104 of 104on this page. Filters & sort apply to loaded results; URL updates for sharing.104 of 104 on this page
BioAtla Axes 70% of Staff, Exploring Strategic Options Amidst Industry ...
BioAtla rakes in $72.5M Series D, advancing research for pH-detecting ...
BioAtla logo in transparent PNG and vectorized SVG formats
BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M ...
BioAtla & GATC Health: Oz-V Phase III Oncology Trial
BioAtla to Complete Merger with BA Merger Sub on April 6
BioAtla (BCAB.O) Plummets 15% Intraday—What’s Behind the Sudden Drop?
BioAtla Virtual R&D Day: BA3071 CAB-CTLA-4 Phase 1 Data Review in ...
BioAtla Investor Presentation Deck | Slidebook.io
BioAtla Announces Upcoming Poster Presentation at the 39th Society for ...
BioAtla August 2025 slides: promising clinical data amid financial ...
BioAtla Reports $69.8 Million Net Loss in 2024 with Promising Clinical ...
BioAtla Join Forces with Context Therapeutics to Develop and ...
BioAtla IPO Presentation Deck | Slidebook.io
BioAtla and GATC Health Announce $40M SPV Transaction to Advance ...
CTCE decorated p53 mRNA-nanoparticles restore the expression of encoded ...
BioAtla Employee Perks & Benefits | Levels.fyi
of CTC counts of resectable ESCC. (A) Enumeration of the CTCE and ...
Impressive Survival Data Sparks Rally for BioAtla Shares - Stocks Today
Post-IPO Equity - BioAtla
Bioatla - AnnualReports.com
Bioatla total equity 2025| Statista
NEWS: BeiGene and BioAtla form worldwide collaboration to develop and ...
BioAtla (BCAB) sets $40M SPV to fund Phase 3 Oz-V OPSCC trial | BCAB ...
BioAtla Reports 21.5-Month Median OS in Refractory Sarcomas | BCAB ...
Last week BioAtla announced a licensing agreement with Context ...
BioAtla Secures $40M for Ozuriftamab Vedotin Phase 3 Trial | AIM Media ...
BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS | | bdavison ...
国外Biotech公司ADC产品技术特色
BioAtla_百度百科
What Is BioAtla’s IPO Date and Price?
BioAtla, Inc. (NASDAQ:BCAB) Sees Significant Increase in Short Interest ...
BioAtla条件性pH激活抗 EpCAM x CD3 双特异性抗体设计 - 知乎
Effective Presentation Design for BioAtla's Cancer Therapy Innovations ...
BCAB Q3 2025 Earnings Report on 11/13/2025
BioAtla, Inc. | LinkedIn
国外Biotech公司ADC产品技术特色医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Bridgewest Group: Empowering people through business investment
ACROBiosystems Recombinant Protein;Biotinylated Human CTLA-4, Fc Tag ...
CAB-AXL-ADC新药早期临床结果积极，BioAtla盘前飙升47%医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Spatiotemporal Basis of CTLA-4 Costimulatory Molecule-Mediated Negative ...
Mechanism of action: CTLA-4 and anti-CTLA-4 antibodies. Two signals are ...
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor ...
Internalization of the CTCE-9908c peptide in human breast cancer cells ...
Comparison of representative SEM images of CTCe, CeF, CeFB, CeMS and ...
CTLA-4 Antibodies: How to Achieve a Breakthrough in Balancing Efficacy ...
slide75
Immune-escape mechanisms of CTCs and collaboration with blood cells to ...
BIOCARTA_CTLA4_PATHWAY
Life Science Cares San Diego on LinkedIn: We are thrilled to announce ...
CTCE-KLAK conjugate induces necrotic cell death in the breast cancer ...
Melanoma investor presentations and pitch decks | Slidebook
BCAB Q2 2025 Earnings Report on 8/7/2025
BCAB Q4 2024 Earnings Report on 3/27/2025
BioAlta Yorkville
How to Choose an Anti-CTLA-4 Antibody for Your Research - Bio-Connect
BioAtla’s New Funding: A Double-Edged Sword for Shareholders
BioAtla, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Tumor objective response to cTACE or TILA-TACE according to EASL ...
Consejo Técnico Consultivo Escolar ENBA | IPN Oficial
Landing Image
Bioatla宣布CAB-AXL-ADC產品IND申請獲得FDA批准丨醫麥優企秀 - 每日頭條
CTLA-4 on thymic epithelial cells complements Aire for T cell central ...
BioAtla's Big Reveal: What to Expect from Q4 2024 Earnings
Consejo Técnico Consultivo Escolar | IPN Oficial
23andMe Investor Presentation Deck | Slidebook.io
行业新闻_江苏巨莱生物医药有限公司
BioAtla’s Ozuriftamab Vedotin Receives FDA Fast Track Designation for ...
BA3011-002 NSCLC interim analysis BA3011 Monotherapy 1.8 mg/kg ...
.jpg)
